Cerus Corporation (NASDAQ: CERS)’s Stock Reduces -2.69%, But It May Be Worthwhile To Invest In

The trading price of Cerus Corporation (NASDAQ:CERS) closed lower on Friday, February 03, closing at $3.25, -2.69% lower than its previous close.

Traders who pay close attention to intraday price movement should know that it fluctuated between $3.21 and $3.34. In examining the 52-week price action we see that the stock hit a 52-week high of $6.00 and a 52-week low of $2.53. Over the past month, the stock has lost -14.70% in value.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases “World’s Most Powerful Data Center CPU”. It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We’ve put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Cerus Corporation, whose market valuation is $592.61 million at the time of this writing, is expected to release its quarterly earnings report Feb 20, 2023 – Feb 24, 2023. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.06 per share this quarter, however they have predicted annual earnings per share of -$0.24 for 2022 and -$0.21 for 2023. It means analysts are expecting annual earnings per share growth of 25.00% this year and 12.50% next year.

Analysts have forecast the company to bring in revenue of $44.55 million for the current quarter, with the likely lows of $40.4 million and highs of $47.6 million. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2022 is $174.52 million. The company’s revenue is forecast to grow by 33.40% over what it did in 2022.

A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Cerus Corporation No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CERS has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.

Here is the average analyst rating on the stock as represented by 1.00 to 5.00, with the extremes of 1.00 and 5.00 suggesting the stock should be considered as either strong buy or strong sell respectively. The number of analysts that have assigned CERS a recommendation rating is 5. Out of them, 2 rate it a Hold, while 3 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged Cerus Corporation (CERS) as Underweight, while 0 advise Sell. Analysts have rated the stock Overweight, likely urging investors to take advantage of the opportunity to add to their holdings of the company’s shares.

A quick review shows that CERS’s price is currently 3.21% off the SMA20 and -9.40% off the SMA50. The RSI metric on the 14-day chart is currently showing 48.10, and weekly volatility stands at 4.84%. When measured over the past 30 days, the indicator reaches 6.95%. Cerus Corporation (NASDAQ:CERS)’s beta value is currently sitting at 0.98, while the Average True Range indicator is currently displaying 0.19. With analysts defining $3.75-$11.50 as the low and high price targets, we arrive at a consensus price target of $8.25 for the trailing 12-month period. The current price is about -15.38% off the estimated low and -253.85% off the forecast high, based on this estimate. Investors will be thrilled if CERS’s share price rises to $10.00, which is the median consensus price. At that level, CERS’s share price would be -207.69% below current price.

To see how Cerus Corporation stock has been performing in comparison to its peers in the industry, here are the numbers: CERS stock’s performance was -2.69% in the latest trading, and -36.65% in the past year, while Haemonetics Corporation (HAE) has traded 0.88% on the day and positioned 86.57% higher than it was a year ago. Also in last trading session, the S&P 500 Index has plunged -1.04%, while the Dow Jones Industrial also saw a negative session, down -0.38% on the day.

An evaluation of the daily trading volume of Cerus Corporation (NASDAQ:CERS) indicates that the 3-month average is 1.35 million. However, this figure has increased over the past 10 days to an average of 1.29 million.

Currently, records show that 177.24 million of the company’s shares remain outstanding. The insiders hold 0.30% of outstanding shares, whereas institutions hold 81.20%. The stats also highlight that short interest as of Oct 13, 2022, stood at 7.13 million shares, resulting in a short ratio of 5.07 at that time. From this, we can conclude that short interest is 4.03% of the company’s total outstanding shares. It is noteworthy that short shares in October were up slightly from the previous month’s figure, which was 6.89 million. However, since the stock’s price has seen -10.96% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.